Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled study of trimetazidine for liver failure
ChiCTR-OPC-15006839Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimetazidine in hepatic failure (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Alanine aminotransferase, Aspartate aminotransferase and 2 more. Started Dec 2014; status: recruiting.
02
Drugs
trimetazidine
03
Conditions
hepatic failure
Beyond the preview
Go deeper on ChiCTR-OPC-15006839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006839.